(33) demonstrated in a mouse model that the combination of CTLA-4 with gemcitabine could foster the expansion of CD4 + and CD8 + T cells, consequently averting T cell exhaustion and loss of function, ultimately resulting in tumor cell demise. The gene discussed is CD8A; the disease is neoplasm.